Waverton Investment Management Ltd lowered its stake in Henry Schein Inc. (NASDAQ:HSIC) by 0.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,284 shares of the company’s stock after selling 35 shares during the period. Waverton Investment Management Ltd’s holdings in Henry Schein were worth $3,056,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of HSIC. Zebra Capital Management LLC boosted its position in shares of Henry Schein by 30.4% in the first quarter. Zebra Capital Management LLC now owns 7,854 shares of the company’s stock valued at $1,356,000 after buying an additional 1,833 shares during the period. Canada Pension Plan Investment Board boosted its position in shares of Henry Schein by 214.1% in the first quarter. Canada Pension Plan Investment Board now owns 26,101 shares of the company’s stock valued at $4,506,000 after buying an additional 17,791 shares during the period. Meiji Yasuda Asset Management Co Ltd. boosted its position in shares of Henry Schein by 60.0% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 2,586 shares of the company’s stock valued at $446,000 after buying an additional 970 shares during the period. Carnick & Kubik LLC acquired a new position in shares of Henry Schein during the first quarter valued at about $1,447,000. Finally, Massmutual Trust Co. FSB ADV boosted its position in shares of Henry Schein by 4.0% in the first quarter. Massmutual Trust Co. FSB ADV now owns 5,129 shares of the company’s stock valued at $885,000 after buying an additional 197 shares during the period. Institutional investors and hedge funds own 91.98% of the company’s stock.
Henry Schein Inc. (NASDAQ:HSIC) traded up 1.04% on Thursday, reaching $163.01. 293,874 shares of the company’s stock were exchanged. The firm has a 50-day moving average price of $162.55 and a 200-day moving average price of $170.55. Henry Schein Inc. has a 1-year low of $137.70 and a 1-year high of $183.00. The company has a market capitalization of $13.33 billion, a P/E ratio of 27.61 and a beta of 1.05.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Thursday, August 4th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.63 by $0.01. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The business earned $2.87 billion during the quarter, compared to analysts’ expectations of $2.85 billion. During the same quarter in the prior year, the business posted $1.46 EPS. The company’s revenue for the quarter was up 9.3% on a year-over-year basis. Equities research analysts expect that Henry Schein Inc. will post $6.57 earnings per share for the current year.
HSIC has been the subject of several recent research reports. Zacks Investment Research cut shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Tuesday, September 20th. Bank of America Corp. initiated coverage on shares of Henry Schein in a report on Monday, September 12th. They set a “buy” rating and a $185.00 target price for the company. Finally, Robert W. Baird reissued an “outperform” rating and set a $176.00 target price (up previously from $175.00) on shares of Henry Schein in a report on Tuesday. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Henry Schein presently has an average rating of “Hold” and an average target price of $157.92.
In other news, Director Paul Brons sold 3,381 shares of the company’s stock in a transaction on Monday, August 29th. The shares were sold at an average price of $164.03, for a total value of $554,585.43. Following the completion of the transaction, the director now owns 13,715 shares in the company, valued at approximately $2,249,671.45. The sale was disclosed in a document filed with the SEC, which is available at this link. 1.27% of the stock is currently owned by insiders.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.